Neuron-specific enolase in hypertension patients with acute ischemic stroke and its value forecasting long-term functional outcomes
Tóm tắt
Neuron Specific Enolase (NSE), a neuro-biochemical protein marker, may correlate with the prognosis of stroke patients. Moreover, hypertension is the most common comorbidities in patients with acute ischemic stroke (AIS), and the relationship between NSE levels and long-term functional outcomes in such an increasingly large population is unclear. The aim of the study was to investigate the relationships mentioned above and optimize the prediction models. From 2018 to 2020, 1086 admissions for AIS were grouped as hypertension and non-hypertension, while hypertension group was randomly divided into development and validation cohorts for internal validation. The severity of the stroke was staged by National Institutes of Health Stroke Scale (NIHSS) score. Stroke prognosis after 1 year of follow up was documented by modified Rankin Scale (mRS) score. Analysis revealed the following findings:(i) Serum NSE levels increased greatly in hypertension subjects with poor functional outcomes(p = 0.046). However, there was no association in non-hypertension individuals(p = 0.386). (ii) In addition to the conventional factors (age and NIHSS score), NSE (OR:1.241, 95% CI: 1.025–1.502) and prothrombin time were significantly related to the incidence of unfavorable outcomes. (iii)Based on the above four indicators, a novel nomogram was established to predict the prognosis of stoke in hypertension patients with the c-index values of 0.8851. Overall, high baseline NSE is associated with poor 1-year AIS outcomes in hypertension patients, suggesting NSE may be a potential prognostic and therapeutic target for stroke in hypertension patients.
Tài liệu tham khảo
Global. Regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the global burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877–97.
Ding Q, et al. Global, Regional, and National Burden of ischemic stroke, 1990–2019. Neurology. 2022;98(3):e279–90.
Kaji R. Global burden of neurological diseases highlights stroke. Nat Rev Neurol. 2019;15(7):371–2.
Zaheer S, et al. Correlation between serum neuron specific enolase and functional neurological outcome in patients of acute ischemic stroke. Ann Indian Acad Neurol. 2013;16(4):504–8.
Wiberg S, et al. Single versus serial measurements of neuron-specific enolase and prediction of poor neurological outcome in persistently unconscious patients after Out-Of-Hospital cardiac arrest - A TTM-Trial Substudy. PLoS ONE. 2017;12(1):e0168894.
Egea-Guerrero JJ, et al. [An experimental model of mass-type brain damage in the rat: expression of brain damage based on neurospecific enolase and protein S100B]. Med Intensiva. 2014;38(4):218–25.
Singh HV, et al. Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit. Clin Chim Acta. 2013;419:136–8.
Streitbürger DP, et al. Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - a combined serum, gene expression and MRI study. PLoS ONE. 2012;7(8):e43284.
Gonzalez-Quevedo A, et al. Serum neuron specific enolase could predict subclinical brain damage and the subsequent occurrence of brain related vascular events during follow up in essential hypertension. J Neurol Sci. 2016;363:158–63.
Cipolla MJ, Liebeskind DS, Chan SL. The importance of comorbidities in ischemic stroke: impact of hypertension on the cerebral circulation. J Cereb Blood Flow Metab. 2018;38(12):2129–49.
Paciaroni M, et al. Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke. 2008;39(8):2249–56.
Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension. 2004;43(1):18–24.
Dagonnier M, et al. Acute stroke biomarkers: are we there yet? Front Neurol. 2021;12:619721.
Du C, et al. Prediction of poor outcome in Intracerebral Hemorrhage based on computed tomography markers. Cerebrovasc Dis. 2020;49(5):556–62.
Gao Z, et al. Nomograms for predicting overall survival and cancer-specific survival of chondroblastic osteosarcoma patients. J Surg Oncol. 2020;122(8):1676–84.
Wang Z, et al. Nomogram Analysis and Internal Validation to predict the risk of Cystobiliary Communication in Patients undergoing hydatid liver cyst surgery. World J Surg. 2020;44(11):3884–92.
Carey R, Moran A, Whelton PJJ. Treat Hypertension: Rev. 2022;328(18):1849–61.
Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38(3):1091–6.
Nasution IK, Bangun S. Relationship between Neuron-specific enolase serum levels with lesion volume and clinical outcome in Acute Stroke Patients. Open Access Macedonian Journal of Medical Sciences. 2022;10(B):324–9.
Ospanov O, Ospanova K, Kadyrova I. Neuron- specific enolase level in patients with metabolic syndrome and its value forecasting acute stroke. Australasian Med J, 2018. 11(3).
Chupel M et al. Exercise and taurine in inflammation, cognition, and peripheral markers of blood-brain barrier integrity in older women. 2018. 43(7): p. 733–41.
Land WJTr. Emerging role of innate immunity in organ transplantation part II: potential of damage-associated molecular patterns to generate immunostimulatory dendritic cells. 2012. 26(2): p. 73–87.
Bharosay A, et al. Correlation of Brain Biomarker Neuron Specific Enolase (NSE) with degree of disability and neurological worsening in Cerebrovascular Stroke. Indian J Clin Biochem. 2012;27(2):186–90.
Haque A et al. New Insights into the Role of Neuron-Specific Enolase in Neuro-Inflammation, Neurodegeneration, and Neuroprotection. Brain Sci, 2018. 8(2).
Hafner A, Obermajer N, Kos J. γ-Enolase C-terminal peptide promotes cell survival and neurite outgrowth by activation of the PI3K/Akt and MAPK/ERK signalling pathways. Biochem J. 2012;443(2):439–50.
Polcyn R, et al. Neuron specific enolase is a potential target for regulating neuronal cell survival and death: implications in neurodegeneration and regeneration. Neuroimmunol Neuroinflamm. 2017;4:254–7.
Zheng J, et al. Mitogen activated protein kinase signaling pathways participate in the active principle region of Buyang Huanwu decoction-induced differentiation of bone marrow mesenchymal stem cells. Neural Regen Res. 2012;7(18):1370–7.
Chakrabarti M, et al. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration. Brain Res Bull. 2014;109:22–31.
Samantaray S, et al. Inhibition of calpain activation protects MPTP-Induced Nigral and spinal cord neurodegeneration, reduces inflammation, and improves Gait Dynamics in mice. Mol Neurobiol. 2015;52(2):1054–66.
Samantaray S, et al. Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay. Neurochem Res. 2011;36(10):1809–16.